# Investigating MPXV Viral Clearance in Mpox Cases and Secondary Attack Rate in Contacts

> **NCT07267390** · — · COMPLETED · sponsor: **Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia** · enrollment: 550 (actual)

## Conditions studied

- Mpox (Monkeypox)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07267390
- **Lead sponsor:** Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-10-31
- **Primary completion:** 2026-02-27
- **Final completion:** 2026-02-27
- **Target enrollment:** 550 (ACTUAL)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07267390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07267390, "Investigating MPXV Viral Clearance in Mpox Cases and Secondary Attack Rate in Contacts". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07267390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
